This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alliance For Lupus NYC Walk With Us To Cure Lupus First Lupus Walk In History To Raise $1-Million

$1 Million for Lupus Research

NEW YORK, Oct. 27, 2011 /PRNewswire-USNewswire/ -- A milestone in lupus research was met this weekend!  On Saturday, October 22 nd the Alliance for Lupus Research (ALR) held its 8th annual New York City Walk with Us to Cure Lupus.  The beautiful weather at Battery Park was matched by the enthusiasm of the nearly 3000 walkers in attendance to walk for the cure.  The walkers were joined by NYC master of ceremonies, My9 news anchor Brenda Blackmon, ALR Chairman Robert Wood Johnson IV, and Walk Co-chairs Frank Bisignano, Chief Administrative Officer JPMorgan Chase; Daniel LaVecchia, Executive Managing Director BGC Partners; and Mark Wagar, President & CEO Empire BlueCross BlueShield.  Spoken poet Shanelle Gabriel inspired the crowd with "Vanity", her moving personal account of life with lupus. 

The ALR NYC Walk with Us to Cure Lupus is the first lupus Walk in history to raise $1 million!  That's $1 million to fund research supporting the ALR's mission of finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus).   Not only did the ALR surpass the Walk's initial goal of $900,000; we made history.  The Walk provided a wonderful opportunity to give a voice to people affected by lupus.  We thank everyone for their support and unwavering commitment.

The Walk was supported by corporate sponsors Johnson & Johnson, Cantor Fitzgerald, BGC Partners, JPMorgan Chase, Empire BlueCross BlueShield, New York Yankees, New York Mets, Trump Organization, KPF Associates, Bank of America/Merrill Lynch, Human Genome Sciences, Pfizer, Montefiore The University Hospital for Albert Einstein College of Medicine, Bank of New York Mellon, KPMG, Verizon, Kraft Foods, CBS Sports, and Turner Construction Company.

About LupusSystemic lupus erythematosus (SLE, or lupus) is a chronic autoimmune disease that can affect the joints and almost every major organ in the body, including the heart, kidneys, skin, lungs, and brain.  As many as 1.5 million people in the United States have lupus which affects mostly women during childbearing years, though men and children can have the disease.  Lupus is three times more common in African-American women than in Caucasian women and is also more prevalent in women of Latino, Asian, and Native American descent. About the ALRThe Alliance for Lupus Research (ALR) is a national voluntary health organization dedicated to finding better treatments and ultimately preventing and curing systemic lupus erythematosus (SLE, or lupus), a debilitating autoimmune disease.  The organization is based in New York City and chaired by Robert Wood Johnson IV, a member of the founding family of Johnson & Johnson.  Since its founding in 1999, the ALR has given more money to lupus research than any non-governmental agency in the world.  The board of directors funds all administrative and fundraising costs, allowing one hundred percent of all donations from the public, and the proceeds of our signature grassroots fundraising program, Walk with Us to Cure Lupus, go directly to support research programs.  The organization has awarded more than $6 million in grants this year and, since 1999, has dedicated over $67 million to understanding the disease. More information can be found at www.lupusresearch.org.

SOURCE Alliance for Lupus Research

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs